BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Reenaers C, Belaiche J, Louis E. Impact of medical therapies on inflammatory bowel disease complication rate. World J Gastroenterol 2012; 18(29): 3823-3827 [PMID: 22876033 DOI: 10.3748/wjg.v18.i29.3823]
URL: https://www.wjgnet.com/1007-9327/full/v18/i29/3823.htm
Number Citing Articles
1
Ellen H. Bailey, Sean C. Glasgow. Challenges in the Medical and Surgical Management of Chronic Inflammatory Bowel DiseaseSurgical Clinics of North America 2015; 95(6): 1233 doi: 10.1016/j.suc.2015.08.003
2
Mariabeatrice Principi, Maria Principia Scavo, Domenico Piscitelli, Vincenzo Villanacci, Rosa Lovero, Giuseppe Losurdo, Bruna Girardi, Enzo Ierardi, Alfredo Di Leo. The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinomaScandinavian Journal of Gastroenterology 2015; 50(8): 1002 doi: 10.3109/00365521.2014.978817
3
Rebecca Faleiro, Ji Liu, Deshapriya Karunarathne, Aleksandra Edmundson, Clay Winterford, Tam Hong Nguyen, Lisa A Simms, Graham Radford‐Smith, Michelle Wykes. Crohn's disease is facilitated by a disturbance of programmed death‐1 ligand 2 on blood dendritic cellsClinical & Translational Immunology 2019; 8(7) doi: 10.1002/cti2.1071
4
Mariabeatrice Principi, Michele Barone, Maria Pricci, Nicola De Tullio, Giuseppe Losurdo, Enzo Ierardi, Alfredo Di Leo. Ulcerative colitis: From inflammation to cancer. Do estrogen receptors have a role?World Journal of Gastroenterology 2014; 20(33): 11496-11504 doi: 10.3748/wjg.v20.i33.11496
5
Derrick D. Eichele, Renee Young. Medical Management of Inflammatory Bowel DiseaseSurgical Clinics of North America 2019; 99(6): 1223 doi: 10.1016/j.suc.2019.08.011
6
Viraj C. Kariyawasam, Fadi H. Mourad, Nikola Mitrev, Sudarshan Paramsothy, Christian P. Selinger, Peter H. Katelaris, Brian Jones, Charles McDonald, Gavin Barr, Grace Chapman, James Cowlishaw, Jane Andrews, Rupert W. Leong. Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitisEuropean Journal of Gastroenterology & Hepatology 2021; 33(12): 1524 doi: 10.1097/MEG.0000000000002101
7
Jin Seok Park, Tac-Ghee Yi, Jong-Min Park, Young Min Han, Jun-Hyung Kim, Dong-Hee Shin, Seon Ji Tak, Kyuheon Lee, Youn Sook Lee, Myung-Shin Jeon, Ki-Baik Hahm, Sun U Song, Seok Hee Park. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel diseaseJournal of Clinical Biochemistry and Nutrition 2015; 57(3): 192 doi: 10.3164/jcbn.15-56
8
Perrine Burdeyron, Sébastien Giraud, Thierry Hauet, Clara Steichen. Urine-derived stem/progenitor cells: A focus on their characterization and potentialWorld Journal of Stem Cells 2020; 12(10): 1080-1096 doi: 10.4252/wjsc.v12.i10.1080
9
Fernanda F CORRÊA, Vera L SDEPANIAN. BODY IRON STATUS INDICATORS AND INFLAMMATION INDICATORS DURING INFLAMMATORY BOWEL DISEASE THERAPY IN CHILDREN AND ADOLESCENTESArquivos de Gastroenterologia 2021; 58(1): 48 doi: 10.1590/s0004-2803.202100000-09
10
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancerJournal of Coloproctology 2017; 37(01): 055 doi: 10.1016/j.jcol.2016.06.005
11
Duy Vu Le, Renuka Gupte, Meghan Hufstader Gabriel, Varun Vaidya. Inflammatory bowel disease: cost-driving factors and impact of cost sharing on outpatient resource utilizationJournal of Pharmaceutical Health Services Research 2018; 9(4): 301 doi: 10.1111/jphs.12244